24.09.2012 Views

Annual Report 1998

Annual Report 1998

Annual Report 1998

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

44<br />

Board of Directors’ report *<br />

CHANGE IN SCA GROUP STRUCTURE<br />

In 1997 it was decided to establish a so-called Control Agreement<br />

between SCA and PWA, to be effective in <strong>1998</strong>. The<br />

Control Agreement creates conditions for implementing<br />

desired structural changes and facilitates the continuing integration<br />

of PWA and SCA. The integration measures that continued<br />

in <strong>1998</strong> included establishment of a common legal organization<br />

for hygiene-products operations. The packaging<br />

operations in PWA were also transferred to SCA Packaging.<br />

During the autumn the name of PWA AG was changed to SCA<br />

Hygiene Products AG.<br />

CAPITAL EXPENDITURES AND ACQUISITIONS<br />

In addition to current capital expenditures of SEK 2,058 M,<br />

strategic capital expenditures amounting to SEK 2,248 M were<br />

made during the year, with Hygiene Products accounting for<br />

SEK 1,617 M and Packaging for SEK 512 M. Projects within<br />

Hygiene Products include a new tissue machine and converting<br />

capacity for tissue in Mannheim, Germany, new capacity in the<br />

incontinence segment and establishment of new production<br />

technologies for baby diapers. The capital expenditure in<br />

Mannheim is estimated at SEK 1,400 M and is being carried<br />

out during the period <strong>1998</strong>–2000, with most activity in 1999.<br />

In the Packaging field, capital expenditures include rebuilding<br />

and new construction in Obbola, Sweden, and Witzenhausen,<br />

Germany, as well as new converting technology for corrugated<br />

board at several production plants.<br />

SCA’s acquisitions during <strong>1998</strong> and certain acquisition at<br />

the beginning of 1999 are presented below in the business area<br />

sections. In total, acquisitions in <strong>1998</strong> amounted to SEK<br />

2,793 M, including the additional purchase of PWA shares.<br />

As of 31 December <strong>1998</strong>, SCA held 96% of PWA’s shares.<br />

Hygiene Products<br />

Early in <strong>1998</strong> the Hygiene Products business area acquired<br />

Marpo, a Spanish tissue company with annual sales of approximately<br />

SEK 550 M. The purchase price was approximately<br />

six times Marpo’s 1997 operating profit.<br />

In Russia, SCA acquired all the shares of Svetogorsk Tissue<br />

for approximately SEK 200 M. Svetogorsk Tissue, which is<br />

located in the St. Petersburg region, has Russia’s most modern<br />

tissue machine, built in 1989.<br />

During <strong>1998</strong> the business area increased its holding in<br />

Productos Familia, a Colombian tissue company, to 50%,<br />

which in turn acquired all the shares of the Tecnopapel tissue<br />

company in Ecuador.<br />

Previously announced plans to acquire a shareholding in the<br />

Melhoramentos tissue company in Brazil have not yet been<br />

completed as a result of the financial uncertainty prevailing in<br />

the country.<br />

The business area also acquired three retailers of incontinence<br />

products in France with total annual sales of SEK<br />

140 M.<br />

Involvement in Asia was increased through acquisition of<br />

a Philippine tissue company. The purchase price was SEK<br />

130 M.<br />

Packaging<br />

In the beginning of <strong>1998</strong> the Packaging business area acquired<br />

a minority interest in the corrugated board operations of the<br />

Spanish company Lantero. SCA paid SEK 196 M for 25% of<br />

the share capital and has an option to increase its holding to<br />

49%.<br />

The business area will acquire a 49% interest in OBALEX,<br />

a Czech packaging company with annual sales of SEK 260 M.<br />

The acquisition is being made in two stages; 33% of the shares<br />

were acquired in <strong>1998</strong> and the remaining shares, up to 49% of<br />

the total, are being acquired in 1999. SCA has an option to buy<br />

the remaining shares.<br />

In the beginning of 1999 the corrugated board division of<br />

Rexam Plc was acquired. The purchase price was approximately<br />

SEK 2,600 M, equal to about 6.5 times the operating<br />

surplus and about 9 times the operating profit, based on estimated<br />

results for <strong>1998</strong>. The business has sales of approximately<br />

SEK 2,700 M. The acquisition increases SCA’s share of the<br />

market for corrugated board in Great Britain from 13% to<br />

21%, and from 13% to 14% in Europe.<br />

Danapak Papemballage, the third largest packaging company<br />

in Denmark, was acquired in January 1999 for SEK<br />

636 M. The purchase price corresponds to eight times operating<br />

profit for <strong>1998</strong>. <strong>Annual</strong>ly, the company produces about<br />

100 million m 2 of corrugated board and has sales of SEK<br />

650 M.<br />

During <strong>1998</strong> the business area acquired all shares outstanding<br />

in the Widmer-Walty Group in Switzerland.<br />

In early 1999, SCA acquired an 11% interest in a Singapore-based<br />

packaging company for SEK 36 M. SCA has the<br />

possibility of increasing ownership to 51% within five years.<br />

The company produces about 50 million m 2 of corrugated<br />

board annually.<br />

Graphic Paper<br />

During <strong>1998</strong>, Graphic Paper acquired additional shares in<br />

Laarkirchen AG for SEK 44 M. Currently, compulsory redemption<br />

is under way of the remaining shares. The remaining<br />

purchase amount, SEK 54 M, will be paid during the first quarter<br />

of 1999.<br />

DIVESTMENTS<br />

SCA divested the Clinical Products business unit (surgical and<br />

wound-care products) in the beginning of <strong>1998</strong>. The sale<br />

amounted to approximately SEK 1,500 M, resulting in a<br />

capital gain of SEK 400 M, which was reported during the first<br />

quarter of <strong>1998</strong>.<br />

RESTRUCTURING<br />

The integration of the Group’s tissue and fluff operations is<br />

continuing. SCA’s plants in the hygiene sector in France are<br />

* In addition to these pages, the Board of Directors’ report includes the discussions and analyses accompanying the cash flow statement, statement of earnings and balance<br />

sheet (pages 46, 48 and 50).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!